[New orientation in the pharmacological management of mental retardation].
D000293:Adolescent; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy*; D010080:Oxazoles / Q000627:therapeutic use*; D010389:Pemoline / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D010080:Oxazoles; D010389:Pemoline
Neuvas orientaciones en el tratamiento farmacológico de la deficiencia mental.